Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Immunol.

Sec. Inflammation

This article is part of the Research TopicInflammation, Immunity, and Cancer: New Pathways Towards Therapeutic InnovationView all 20 articles

The Long Pentraxin 3: The Invisible Loom Weaving the Warp and Weft of Tumor Destiny

Provisionally accepted
Tianyi  LiuTianyi Liu1Manyu  LiManyu Li2Yuxi  ChengYuxi Cheng3Jialin  ZouJialin Zou4Fengying  LiuFengying Liu5Jie  DongJie Dong5Cheng  QiuCheng Qiu6Xuenan  PengXuenan Peng7Deyang  KongDeyang Kong7Zhifan  LiZhifan Li7Xinyu  WangXinyu Wang8Lanyu  LiLanyu Li5*
  • 1National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China, Beijing, China
  • 2Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, China
  • 3Lanzhou University First Hospital, Lanzhou, China
  • 4Shandong University State Key Laboratory of Reproductive Medicine and Offspring Health, Jinan, China
  • 5Central Hospital Affiliated to Shandong First Medical University, Jinan, China
  • 6Peking Union Medical College Hospital Department of Orthopedics, Beijing, China
  • 7Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  • 8Beijing Jishuitan Hospital Affiliated to Capital Medical University, Beijing, China

The final, formatted version of the article will be published soon.

Pentraxins, which constitute a family of evolutionarily conserved pattern recognition molecules, are categorized into short and long branches. The long pentraxin 3 (PTX3) is a key member of the long pentraxin subfamily, while the C-reactive protein and serum amyloid P represent the short pentraxins. All pentraxins share a highly conserved C-terminal motif, an 8-amino acid sequence known as the pentraxin signature. PTX3 can be produced by a wide range of cell types, including immune cells such as dendritic cells, monocytes, and macrophages, as well as various non-immune cells, underscoring its pleiotropic roles in multiple pathophysiological processes. These include inflammation, infection, tissue repair, female fertility, and cancer. Although PTX3 engages commonly recognized signaling pathways, such as TNF-α, NF-κB, FGF, and PI3K/AKT, it can exert paradoxical effects in different cellular contexts, either promoting or inhibiting the proliferation, migration, invasion, and metastasis of cancer cells. This review provides a comprehensive overview of the multifaceted roles of PTX3 in various cancers, while also summarizing its functions in other physiological or pathological contexts. Furthermore, we critically examine the challenges and translational opportunities of PTX3, aiming to inform future research directions and therapeutic strategies for cancer management.

Keywords: pentraxins, PTX3, Cancer, biomarker, Epigenetic regulation, Inflammation, Infection, complement

Received: 14 Sep 2025; Accepted: 02 Dec 2025.

Copyright: © 2025 Liu, Li, Cheng, Zou, Liu, Dong, Qiu, Peng, Kong, Li, Wang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Lanyu Li

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.